Literature DB >> 14766879

Development, implementation, and impact of acceptability criteria for serologic tests for infectious diseases.

John A Crump1, Jennifer R Corder, Nancy G Henshaw, L Barth Reller.   

Abstract

Serologic testing is essential for the diagnosis of some infectious diseases and yet is fraught with potential pitfalls. All parts of the diagnostic process must be optimized to ensure that serologic tests perform adequately. Recognizing that a lack of clinical data and correctly timed, paired sera frequently led to uninterpretable serology results at our laboratory, we developed and implemented simple acceptability criteria for serologic tests. We assessed the impact of these criteria by comparing submissions and results for the year before and the year after implementation of the criteria. The number of serologic tests performed declined by 25% after implementation of the acceptability criteria, despite an increase in requests for serologic tests. Inappropriate testing of acute-phase sera alone fell from 49 to 0% (P < 0.001) for the tests monitored. Appropriate submission of paired sera rose from 9 to 19% (P = 0.006). The proportion of results classified as interpretable rose from 52 to 100% (P < 0.001). We recommend that acceptability criteria be developed and applied to samples submitted to clinical microbiology laboratories for serologic testing.

Entities:  

Mesh:

Year:  2004        PMID: 14766879      PMCID: PMC344489          DOI: 10.1128/JCM.42.2.881-883.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Microscopic and baceriologic analysis of expectorated sputum.

Authors:  P R Murray; J A Washington
Journal:  Mayo Clin Proc       Date:  1975-06       Impact factor: 7.616

2.  Issues in cerebrospinal fluid management. Acid-fast bacillus smear and culture.

Authors:  R E Albright; C B Graham; R H Christenson; W A Schell; M C Bledsoe; J L Emlet; T P Mears; L B Reller; K A Schneider
Journal:  Am J Clin Pathol       Date:  1991-03       Impact factor: 2.493

3.  Rejection criteria for endotracheal aspirates from adults.

Authors:  A J Morris; D C Tanner; L B Reller
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

4.  Cost and time savings following introduction of rejection criteria for clinical specimens.

Authors:  A J Morris; L K Smith; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

5.  Effective use of polymerase chain reaction for diagnosis of central nervous system infections.

Authors:  Y W Tang; J R Hibbs; K R Tau; Q Qian; H A Skarhus; T F Smith; D H Persing
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

6.  Application of rejection criteria for stool ovum and parasite examinations.

Authors:  A J Morris; M L Wilson; L B Reller
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

7.  Application of rejection criteria for stool cultures for bacterial enteric pathogens.

Authors:  K Fan; A J Morris; L B Reller
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

  7 in total
  2 in total

1.  Seroepidemiologic study of human infections with spotted fever group Rickettsiae in North Carolina.

Authors:  Meagan F Vaughn; Josie Delisle; Joey Johnson; Gaylen Daves; Carl Williams; Jodi Reber; Nicole L Mendell; Donald H Bouyer; William L Nicholson; Abelardo C Moncayo; Steven R Meshnick
Journal:  J Clin Microbiol       Date:  2014-09-03       Impact factor: 5.948

2.  Large regional differences in serological follow-up of Q fever patients in the Netherlands.

Authors:  Gabriëlla Morroy; Cornelia C H Wielders; Mandy J B Kruisbergen; Wim van der Hoek; Jan H Marcelis; Marjolijn C A Wegdam-Blans; Clementine J Wijkmans; Peter M Schneeberger
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.